Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Olive Fertility Centre Co-Director Commended for his Term as President of Canadian Fertility and Andrology Society for 2020-2021

Dr Hitkari assumed the role of President during the COVID 19 pandemic and has provided critical leadership during this time of disruption and change in the field of assisted reproduction.


News provided by

Olive Fertility Centre

Sep 20, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


VANCOUVER, British Columbia, Sept. 20, 2021 /PRNewswire-PRWeb/ -- Olive Fertility Centre and Canadian Fertility and Andrology Society (CFAS) would like to congratulate Dr Jason Hitkari, Olive co-founder-and co-director, on successfully completing his term as the CFAS President.

Dr Hitkari served as President of the Canadian Fertility and Andrology Society (CFAS) for the 2020-2021 term. He assumed the role of President during the COVID 19 pandemic and has provided critical leadership during this time of disruption and change in the field of assisted reproduction.

With all COVID’s uncertainties, Jason was a calm and reassuring leader for the CFAS Board and team.

Post this

"It has been a pleasure working with Dr Jason Hitkari as the Canadian Fertility and Andrology Society (CFAS) President this past year. With all COVID's uncertainties, Jason was a calm and reassuring leader for the CFAS Board and team. Jason assisted us in accomplishing many milestones as CFAS President, including implementing the CFAS compliance seal, updating the CFAS bylaws, completing the 2021-2024 Strategic Plan, and paving the way for the first CFAS hybrid Annual Meeting with both virtual and in-person attendance options. The CFAS is extremely grateful to have had Jason as our President, his collaborative leadership has meant a lot to us over this past year, we thank him for his time, dedication and commitment to the CFAS and its mission."

The Canadian Fertility and Andrology Society is Canada's national organization of professionals dealing with reproductive medicine. Its mission is to responsibly advance reproductive science and medicine in Canada through leadership, research, and guidance.

The COVID 19 pandemic has highlighted the essential role that CFAS plays in providing guidance to reproductive medical professionals and fertility clinics across Canada. Dr Hitkari, along with other CFAS board members, has been instrumental in drafting guiding principles to assist Canadian ART clinics to resume services and care for patients in a safe way.

While the coronavirus pandemic brought on new anxieties and obstacles, it has also provided new opportunities to rethink fertility care. "It's a great honour to have been elected president of CFAS by my peers and to have served during this challenging time," says Dr Hitkari. "We learned how to provide care remotely, how to rethink our offices and clinics to maintain social distancing and prepare for the world as it is now. Ultimately, we were able to continue to provide excellent care even during a global pandemic. In recognition of this accomplishment, the theme for this year's conference is "Thriving through change: from virtual medicine and viruses to technology and techniques."

Dr Hitkari completed his training in Obstetrics and Gynecology at the University of British Columbia (UBC) and went on to do a formal fellowship in Reproductive Endocrinology and Infertility at The University of Toronto (Mt. Sinai). In addition to acting as co-director of Olive Fertility Centre, Dr Hitkari is a Clinical Associate Professor at UBC.

Nationally recognized as a dedicated and award-winning educator, Dr Hitkari coordinates the UBC Medical School undergraduate teaching in the areas of reproduction and infertility. He is a past examiner in Obstetrics and Gynecology at the Royal College of Physicians and Surgeons of Canada. As patient advocate, Dr. Hitkari has served as a board member for the Infertility Awareness Association of Canada and is proud of being the recipient of the H. Hill Humanitarian award for exceptional patient care.

Olive Fertility Centre
Located in Vancouver, BC, Olive Fertility Centre is one of Canada's largest IVF and prenatal diagnosis centres. With an advanced IVF lab, and innovative programs that include Preimplantation Genetic Testing (PGT-A), egg freezing, and prenatal NIPT testing, Olive Fertility (olivefertility.com) provides comprehensive fertility care to infertile couples, single women, and LGBTQ2 individuals.

Media Contact

Mairi Campbell, Personae Concepts, +1 (778) 885-5300, [email protected]

SOURCE Olive Fertility Centre

Modal title

Dr. Jason Hitkari
Dr. Jason Hitkari
Dr. Jason Hitkari

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.